Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Uma Maheswara Rao Ch"'
Autor:
Sailaja Kesiraju, Lakshmi Kiran Chelluri, Sumanlatha Gaddam, Vijaya Lakshmi Valluri, Uma Maheswara Rao Ch, Sahariah Sarbeswar
Publikováno v:
Indian Journal of Transplantation, Vol 12, Iss 1, Pp 53-58 (2018)
Purpose: Kidney injury molecule (KIM)-1, a transmembrane-tubular protein, is excreted in the urine within 12 h of the initial ischemic insult and before regeneration of the epithelium. Cystatin C (CysC) a low-molecular-weight nonglycosylated protein
Externí odkaz:
https://doaj.org/article/6639e642d2d041ce987d7d12d70d4f1f
Autor:
Sailaja Kesiraju, Purna Paritala, Uma Maheswara Rao Ch, Srinivasa Murthy Athmakuri, V S Reddy, S Sahariah
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 25, Iss 1, Pp 9-15 (2014)
Although basiliximab and rabbit anti-thymocyte globulin (ATG) are effective in delaying and reducing the incidence of acute rejection (AR) thus improving short-term graft survival, their impact on long-term graft survival has not been well establishe
Externí odkaz:
https://doaj.org/article/c86da492de2c41d59320e0ce7d0cae89
Autor:
Vijaya Lakshmi Valluri, Lakshmi Kiran Chelluri, Sahariah Sarbeswar, Sailaja Kesiraju, Sumanlatha Gaddam, Uma Maheswara Rao Ch
Publikováno v:
Indian Journal of Transplantation, Vol 12, Iss 1, Pp 53-58 (2018)
Purpose: Kidney injury molecule (KIM)-1, a transmembrane-tubular protein, is excreted in the urine within 12 h of the initial ischemic insult and before regeneration of the epithelium. Cystatin C (CysC) a low-molecular-weight nonglycosylated protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e770ab1bc6ea379d8186230f41edb19
http://www.ijtonline.in/article.asp?issn=2212-0017
http://www.ijtonline.in/article.asp?issn=2212-0017
Autor:
Sailaja Kesiraju, Purna Paritala, Vishwanath Reddy, Sreedhar Reddy, S. Sahariah, Uma Maheswara Rao Ch
Publikováno v:
Immunologic Research. 64:791-794
Achievement of an immunosuppression-free condition defined as clinical operational tolerance is an ideal goal. We hereby report a case of clinical operational tolerance in a patient whose allograft is functioning normally, without immunosuppression,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c942ce3cb8b4478d823aab0039d4ed
https://doi.org/10.1007/s12026-015-8766-6
https://doi.org/10.1007/s12026-015-8766-6
Publikováno v:
Transplant immunology. 30(1)
New onset of diabetes after transplantation (NODAT) is a serious and common complication following solid organ transplantation. NODAT has been reported to occur in 2% to 53% of renal transplant recipients. Several risk factors are associated with NOD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e3bf131ccaca3df96146527046ab186
https://pubmed.ncbi.nlm.nih.gov/24184293
https://pubmed.ncbi.nlm.nih.gov/24184293
Autor:
Srinivasa Murthy Athmakuri, Sailaja Kesiraju, S. Sahariah, V. S. Reddy, Uma Maheswara Rao Ch, Purna Paritala
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 25, Iss 1, Pp 9-15 (2014)
Although basiliximab and rabbit anti-thymocyte globulin (ATG) are effective in delaying and reducing the incidence of acute rejection (AR) thus improving short-term graft survival, their impact on long-term graft survival has not been well establishe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6a6e95fae415d7f500d3ef1a2508b88
https://doi.org/10.4103/1319-2442.124459
https://doi.org/10.4103/1319-2442.124459